Annika Auranen


Adjunct Professor, Department of Clinical Medicine (Department of Clinical Medicine)

anaura@utu.fi







Publications

The Expression of HSD17B12 Is Associated with COX-2 Expression and Is Increased in High-Grade Epithelial Ovarian Cancer (2018)
Oncology
Kemiläinen H., Huhtinen K., Auranen A., Carpén O., Strauss L., Poutanen M.
(
A1 Journal article – refereed)

(18)F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer (2016)
Gynecologic Oncology
Vallius T, Peter A, Auranen A, Carpén O, Kemppainen J, Matomäki J, Oksa S, Roering P, Seppänen M, Grénman S, Hynninen J
(
A1 Journal article – refereed)

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources (2016)
Clinical Chemistry
Gidwani K, Huhtinen K, Kekki H, van Vliet S, Hynninen J, Koivuviita N, Perheentupa A, Poutanen M, Auranen A, Grenman S, Lamminmaki U, Carpen O, van Kooyk Y, Pettersson K
(
A1 Journal article – refereed)

Characterization of ascites and tumor-derived ovarian cancer stem-like cells (2016)
Clinical Cancer Research
Kaipio K, Chen P, Huhtinen K, Mikkonen P, Ostling P, Mpindi JP, Lehtinen L, Roering P, Korpela T, Wennerberg K, Yadav B, Aittokallio T, Kulesskiy E, Hynninen J, Auranen A, Grenman S, Hautaniemi S, Carpen O
(
O2 Other)

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker (2016)
PLoS ONE
Laura Lehtinen, Pia Vesterkvist, Pia Roering, Taina Korpela, Liisa Hattara, Katja Kaipio, John-Patrick Mpindi, Johanna Hynninen, Annika Auranen, Ben Davidson, Caj Haglund, Kristiina Iljin, Seija Grenman, Harri Siitari, Olli Carpen
(
A1 Journal article – refereed)

Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy (2015)
Cancer Research
Chen P, Huhtinen K, Kaipio K, Mikkonen P, Aittomaki V, Lindell R, Hynninen J, Auranen A, Grenman S, Lehtonen R, Carpen O, Hautaniemi S
(
A1 Journal article – refereed)

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma (2015)
Gynecologic Oncology
Edqvist PHD, Huvila J, Forsstrom B, Talve L, Carpen O, Salvesen HB, Krakstad C, Grenman S, Johannesson H, Ljungqvist O, Uhlen M, Ponten F, Auranen A
(
A1 Journal article – refereed)

High-grade serous ovarian cancer subtyping identifies pathways for targeted therapy (2014)
European Journal of Cancer
Huhtinen K, Chen P, Mikkonen P, Kaipio K, Aittomaki V, Lindell R, Auranen A, Lehtonen R, Hautaniemi S, Carpen O
(
O2 Other)

Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. (2014)
Tumor Biology
Vallius Tuulia, Hynninen Johanna, Auranen Annika, Carpén Olli, Matomäki Jaakko, Oksa Sinikka, Virtanen Johanna, Grénman Seija
(
A1 Journal article – refereed)

A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer (2013)
Gynecologic Oncology
Hynninen J, Kemppainen J, Lavonius M, Virtanen J, Matomaki J, Oksa S, Carpen O, Grenman S, Seppanen M, Auranen A
(
A1 Journal article – refereed)

Characterization of primary high-grade serous ovarian cancer cell lines: Cell line and growth condition specific differences in stem cell marker expression and high-throughput drug screening (2013)
Clinical Cancer Research
Roering P, Mikkonen P, Kaipio K, Huhtinen K, Hynninen J, Auranen A, Kulesskiy E, Yadav B, Aittokallio T, Grenman S, Wennerberg K, Carpen O
(
O2 Other)

Identifying prognostically relevant subsets of endometrial cancer using unsupervised clustering of immunohistochemical staining data (2013)
Virchows Archiv
Huvila J, Laajala D, Edqvist PH, Talve L, Grenman S, Ponten F, Aittokallio T, Carpen O, Auranen A
(
O2 Other)

Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy? (2013)
Gynecologic Oncology
Hynninen J, Lavonius M, Oksa S, Grénman S, Carpén O, Auranen A
(
A1 Journal article – refereed)

Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma. (2013)
Gynecologic Oncology
Huvila J, Talve L, Carpén O, Edqvist PH, Pontén F, Grénman S, Auranen A
(
A1 Journal article – refereed)

FDG PET/CT in staging of advanced epithelial ovarian cancer: Frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread (2012)
Gynecologic Oncology
Hynninen J, Auranen A, Carpén O, Dean K, Seppänen M, Kemppainen J, Lavonius M, Lisinen I, Virtanen J, Grénman S
(
A1 Journal article – refereed)

A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families (2011)
Acta Obstetricia et Gynecologica Scandinavica
Auranen Annika, Joutsiniemi Titta
(
A1 Journal article – refereed)

Serum HE4 profile during primary chemotherapy of epithelial ovarian cancer (2011)
International Journal of Gynecological Cancer
Hynninen J, Auranen A, Dean K, Lavonius M, Carpen O, Perheentupa A, Seppänen M, Grénman S
(
A1 Journal article – refereed)

Subspecialist training in surgical gynecologic oncology in the Nordic countries (2011)
Acta Obstetricia et Gynecologica Scandinavica
Antonsen Sofie L, Åvall-Lundqvist Elisabeth, Salvesen Helga B, Auranen Annika, Salvarsdottir Anna, Hogdall Claus
(
A1 Journal article – refereed)

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts (2009)
British Journal of Cancer
Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, Setälä M, Härkki P, Jalkanen J, Fraser J, Mäkinen J, Auranen A, Poutanen M, Perheentupa A
(
A1 Journal article – refereed)


Last updated on 2017-17-11 at 03:42